YML100W-A Antibody

What is YML100W-A and why is it significant in yeast research?

YML100W-A is a gene in Saccharomyces cerevisiae that has been identified in screens for genes conferring resistance to antiproliferative compounds like benzyl isothiocyanate (BITC). When overexpressed, YML100W-A significantly weakens the antiproliferative effect of BITC compared to control groups, suggesting its role in cellular stress responses . Its significance lies in understanding fundamental cellular processes and potential homologous pathways in higher eukaryotes.

What applications are YML100W-A antibodies suitable for?

YML100W-A antibodies are typically employed for Western blotting, immunoprecipitation, and immunofluorescence microscopy. For optimal Western blot results, researchers should consider employing a 12-15% SDS-PAGE system under reducing conditions, similar to protocols used for other yeast proteins . Immunofluorescence applications require appropriate fixation methods, with paraformaldehyde typically yielding better epitope preservation for nuclear proteins.

How should YML100W-A antibodies be stored and handled?

Most YML100W-A antibodies require storage at -20°C to -70°C for long-term stability. Once reconstituted, they generally remain stable at 2-8°C for approximately one month under sterile conditions . Repeated freeze-thaw cycles significantly reduce antibody activity and should be avoided. For maximum shelf life, consider aliquoting the reconstituted antibody into single-use volumes before freezing.

How can YML100W-A antibodies advance understanding of cellular response to antiproliferative agents?

YML100W-A has been identified among 12 genes whose overexpression contributes to BITC resistance in yeast . Antibodies targeting YML100W-A provide crucial tools for investigating how this protein functions within antiproliferative response networks. By combining antibody-based detection with gene expression analysis, researchers can reveal whether resistance mechanisms involve protein level changes, post-translational modifications, or altered subcellular localization patterns.

What is the relationship between YML100W-A and established autophagy/stress response pathways?

While direct evidence linking YML100W-A to specific pathways is limited in current research, its involvement in BITC resistance suggests potential roles in stress response. Yeast autophagy involves numerous proteins like Atg1, whose deletion severely impairs autophagy processes . Antibodies against YML100W-A can help determine whether it functions within these established pathways by enabling co-localization studies with known markers and analysis of expression changes under autophagy-inducing conditions.

What cross-reactivity considerations exist when using YML100W-A antibodies in different yeast species?

Cross-reactivity depends on sequence conservation across species. When designing experiments in non-Saccharomyces yeast like Pichia pastoris, researchers should perform comprehensive validation using appropriate controls. Sequence alignment analysis between YML100W-A homologs can predict potential epitope conservation, while specificity testing using YML100W-A knockout strains provides definitive validation of antibody specificity.

What are the optimal conditions for using YML100W-A antibodies in Western blotting?

For optimal Western blot detection of YML100W-A, researchers should consider:

Similar to detection protocols established for tagged proteins in yeast studies, these conditions facilitate specific detection while minimizing background .

How can I validate the specificity of a YML100W-A antibody?

Rigorous validation requires multiple approaches:

• Compare signal between wild-type and YML100W-A deletion strains

• Perform peptide competition assays to demonstrate binding specificity

• Verify signal increase in strains overexpressing YML100W-A

• Include positive controls with established expression patterns

• Compare results across multiple antibody lots or sources

The alkaline lysis method, as used in peroxisome turnover studies, provides efficient protein extraction from yeast cells for subsequent antibody validation .

What protocols are recommended for YML100W-A immunoprecipitation experiments?

For successful immunoprecipitation:

• Harvest yeast cells during mid-log phase (OD600 ~0.5-0.8)

• Lyse cells using glass bead disruption in non-denaturing buffer

• Pre-clear lysate with Protein A/G beads

• Incubate cleared lysate with YML100W-A antibody (4°C, overnight)

• Capture antibody-protein complexes with fresh Protein A/G beads

• Wash extensively to remove non-specific interactions

• Elute bound proteins using SDS sample buffer or gentle elution buffer

This approach parallels successful immunoprecipitation protocols established for studying protein complexes in yeast cellular pathways .

How can YML100W-A antibodies be used to study protein degradation pathways?

YML100W-A antibodies can reveal degradation kinetics under different conditions, similar to approaches used in pexophagy studies . By monitoring YML100W-A protein levels after transferring cells from nutrient-rich to starvation media, researchers can establish degradation timelines. This approach, coupled with inhibitors of specific degradation pathways, can elucidate whether YML100W-A undergoes selective autophagy, proteasomal degradation, or other turnover mechanisms.

What strategies exist for tracking YML100W-A expression changes across growth conditions?

Quantitative Western blotting using YML100W-A antibodies can track expression across conditions. The table below shows hypothetical relative protein levels based on approaches used in similar yeast studies:

These approaches mirror established protocols for monitoring protein expression changes in yeast under various stress conditions .

How do MAP kinase pathway perturbations affect YML100W-A expression and localization?

MAP kinase pathways, including those involving Hog1 (high osmolarity glycerol 1), significantly impact cellular stress responses in yeast . YML100W-A antibodies can reveal whether this protein is regulated by specific MAP kinase pathways by comparing expression and localization in wild-type versus kinase deletion strains such as Δhog1, Δbck1, or other kinase mutants identified in comprehensive screens .

Why might I observe inconsistent results with YML100W-A antibodies?

Several factors can contribute to inconsistent results:

• Antibody storage conditions (avoid repeated freeze-thaw cycles)

• Variation in extraction efficiency between experiments

• Growth phase differences affecting baseline expression

• Strain background variations influencing protein expression

• Post-translational modifications altering epitope accessibility

Standardizing growth conditions and extraction protocols can significantly improve consistency, as demonstrated in studies of yeast protein detection .

How can I distinguish between specific and non-specific signals in YML100W-A immunoblots?

To distinguish specific signal:

• Always include a YML100W-A deletion strain as negative control

• Consider using epitope-tagged YML100W-A as positive control

• Perform pre-absorption with recombinant antigen

• Compare migration pattern with predicted molecular weight

• Verify signal reduction after RNAi-mediated knockdown

These approaches have proven effective in validating antibody specificity in yeast protein detection systems .

What alternatives exist when YML100W-A antibodies yield suboptimal results?

When antibody-based detection proves challenging, consider:

• Epitope tagging strategies (GFP, TAP, HA) to leverage well-characterized tag antibodies

• Mass spectrometry-based protein identification approaches

• RNA-based expression analysis as proxy for protein levels

• Functional assays to indirectly measure protein activity

• Protein overexpression systems to enhance detection sensitivity

The thiolase-GFP processing assay demonstrates how fusion proteins can facilitate protein monitoring when direct antibody detection is problematic .